Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-10.21%
operating margin TTM
-10.78%
revenue TTM
310.36 Thousand
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -36.74 |
| peg ratio | 0.09 |
| price to book ratio | 3.62 |
| price to sales ratio | 3.81 |
| enterprise value multiple | -40.34 |
| price fair value | 3.62 |
profitability ratios | |
|---|---|
| gross profit margin | 85.54% |
| operating profit margin | -10.78% |
| pretax profit margin | -8.54% |
| net profit margin | -10.21% |
| return on assets | -7.44% |
| return on equity | -9.92% |
| return on capital employed | -9.5% |
liquidity ratio | |
|---|---|
| current ratio | 3.30 |
| quick ratio | 3.04 |
| cash ratio | 1.82 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 157.28 |
| operating cycle | 193.26 |
| days of payables outstanding | 12.16 |
| cash conversion cycle | 181.10 |
| receivables turnover | 10.14 |
| payables turnover | 30.01 |
| inventory turnover | 2.32 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.02 |
| debt equity ratio | 0.02 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.02 |
| interest coverage | 0.00 |
| cash flow to debt ratio | 2.61 |
cash flow ratios | |
|---|---|
| free cash flow per share | 0.36 |
| cash per share | 3.41 |
| operating cash flow per share | 0.36 |
| free cash flow operating cash flow ratio | 0.99 |
| cash flow coverage ratios | 2.61 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 92.74 |
Frequently Asked Questions
When was the last time Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) reported earnings?
Kiniksa Pharmaceuticals, Ltd. (KNSA) published its most recent earnings results on 29-10-2024.
What is Kiniksa Pharmaceuticals, Ltd.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)'s trailing twelve months ROE is -9.92%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Kiniksa Pharmaceuticals, Ltd. (KNSA) currently has a ROA of -7.44%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did KNSA's net profit margin stand at?
KNSA reported a profit margin of -10.21% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is KNSA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.30 in the most recent quarter. The quick ratio stood at 3.04, with a Debt/Eq ratio of 0.02.